Water-soluble adjuvant obtained from Bacterionema matruchotii

Area of Science:

• Immunology
• Microbiology
• Bacteriology

Background:

• Oral bacteria like Bacterionemia matruchotii are sources of novel bioactive compounds.
• Adjuvants are crucial for enhancing immune responses to antigens.
• Understanding bacterial adjuvants can lead to improved vaccine strategies.

Purpose of the Study:

• To investigate the adjuvant properties of a water-soluble extract from Bacterionemia matruchotii (bu-WSA).
• To evaluate the impact of bu-WSA on antibody production at the plaque-forming cell (PFC) level in mice.
• To determine the optimal dosage and timing for bu-WSA administration.

Main Methods:

• Extraction of a water-soluble adjuvant (bu-WSA) from Bacterionemia matruchotii.
• Intraperitoneal injection of bu-WSA in mice, followed by immunization with sheep erythrocytes (SRBC).
• Quantification of direct PFC numbers in murine spleens at various time points post-immunization.

Main Results:

• Bu-WSA significantly increased direct PFC numbers in mouse spleens 1-3 days after SRBC stimulation.
• An optimal adjuvant effect was observed with 400 micrograms of bu-WSA.
• The adjuvant effect was most potent when bu-WSA was administered concurrently with the antigen, but still effective up to 7 days prior or 1 day after immunization.

Conclusions:

• Bu-WSA from Bacterionemia matruchotii exhibits significant adjuvant activity, enhancing antibody responses.
• The adjuvant effect of bu-WSA is dose-dependent and influenced by administration timing relative to antigen exposure.
• Findings suggest that bu-WSA's adjuvant mechanism involves both thymic-dependent and independent pathways.